A STUDY OF THE CORRELATION BETWEEN MORPHOLOGICAL FINDINGS AND BIOLOGICAL ACTIVITIES IN CLINICALLY NONFUNCTIONING PITUITARY ADENOMAS
暂无分享,去创建一个
T. Sano | S. Yamada | K. Takano | A. Takeshita | M. Taguchi | K. Morita | K. Ohyama
[1] L. Pan,et al. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space , 2005, Journal of Neuro-Oncology.
[2] J. Ahlquist,et al. A spectrum of behaviour in silent corticotroph pituitary adenomas , 2005, British journal of neurosurgery.
[3] K. Kovacs,et al. Silent Adenoma Subtype 3 of the Pituitary—Immunohistochemical and Ultrastructural Classification: A Review of 29 Cases , 2005, Ultrastructural pathology.
[4] J. Hainfellner,et al. Expression of cell proliferation markers in pituitary adenomas – correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIα , 2004, Acta Neurochirurgica.
[5] Z. Qian,et al. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness. , 2004, The Journal of clinical endocrinology and metabolism.
[6] D. Okonkwo,et al. Clinical Characteristics of Silent Corticotrophic Adenomas and Creation of an Internet-accessible Database to Facilitate Their Multi-institutional Study , 2003, Neurosurgery.
[7] W. Wilczak,et al. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue , 2003, Acta Neuropathologica.
[8] I. McCutcheon,et al. p53 and MIB-1 Immunohistochemistry as Predictors of the Clinical Behavior of Nonfunctioning Pituitary Adenomas , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[9] Y. Segev,et al. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth , 2003, Clinical endocrinology.
[10] A. Tabarin,et al. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. , 2003, Journal of neurosurgery.
[11] J. Wass,et al. Non‐functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently , 2003, Clinical endocrinology.
[12] J. Kuratsu,et al. Are Nonfunctioning Pituitary Adenomas Extending into the Cavernous Sinus Aggressive and/or Invasive? , 2001, Neurosurgery.
[13] L. Mastronardi,et al. Lack of correlation between Ki-67 labelling index and tumor size of anterior pituitary adenomas , 2001, BMC Cancer.
[14] R. Macaulay,et al. Absent p53 Immunohistochemical Staining in a Pituitary Carcinoma , 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[15] B. Scheithauer,et al. Clinically Silent Corticotroph Tumors of the Pituitary Gland , 2000, Neurosurgery.
[16] K. Kurisu,et al. Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas , 1997, Journal of Neuro-Oncology.
[17] I. Chiodini,et al. Nonfunctioning adenomas of the pituitary. , 1996, Metabolism: Clinical and Experimental.
[18] B. Scheithauer,et al. Gonadotroph adenoma of the pituitary gland: a clinicopathologic analysis of 100 cases. , 1996, Mayo Clinic proceedings.
[19] B. Scheithauer,et al. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. , 1996, Neurosurgery.
[20] C. Matula,et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.
[21] C. Matula,et al. Pituitary Adenomas with Invasion of the Cavernous Sinus Space , 1993 .
[22] S. Asa,et al. Clinically Non-Functioning Human Pituitary Adenomas , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[23] K. Kovacs,et al. Ultrastructural diagnosis of human pituitary adenomas , 1992, Microscopy research and technique.
[24] K. Kovacs,et al. Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age. , 1991, Journal of neurosurgery.
[25] E. Knosp,et al. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. , 1989, Neurosurgery.
[26] T. H. Newton,et al. MR imaging of cavernous sinus involvement by pituitary adenomas. , 1988, AJR. American journal of roentgenology.
[27] B. Scheithauer,et al. Pathology of invasive pituitary tumors with special reference to functional classification. , 1986, Journal of neurosurgery.
[28] B. Scheithauer,et al. The occurrence of dural invasion in pituitary adenomas. , 1986, Journal of neurosurgery.
[29] Gillian E. Wu,et al. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. , 2002, The Journal of clinical investigation.
[30] B. Scheithauer,et al. Pathology of Pituitary Adenomas and Pituitary Hyperplasia , 2001 .
[31] B. Scheithauer,et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. , 1996, Neurosurgery.